# EGEN-5784 Porcine Liver With the Metra® ELC Device

> **NCT07429838** · PHASE1 · NOT_YET_RECRUITING · sponsor: **eGenesis, INC** · enrollment: 20 (estimated)

## Conditions studied

- Acute on Chronic Liver Failure (ACLF)
- Hepatic Encephalopathy (HE)

## Interventions

- **DEVICE:** metra® Extracorporeal Liver Cross-Circulation (ELC) system (OrganOx)
- **BIOLOGICAL:** EGEN-5784 (genetically engineered porcine liver)

## Key facts

- **NCT ID:** NCT07429838
- **Lead sponsor:** eGenesis, INC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-12
- **Final completion:** 2028-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429838, "EGEN-5784 Porcine Liver With the Metra® ELC Device". Retrieved via AI Analytics 2026-09-02 from https://api.ai-analytics.org/clinical/NCT07429838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*